Literature DB >> 15499549

Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation.

Jiong Tao1, Hilde Van Esch, M Hagedorn-Greiwe, Kirsten Hoffmann, Bettina Moser, Martine Raynaud, Jürgen Sperner, Jean-Pierre Fryns, Eberhard Schwinger, Jozef Gécz, Hans-Hilger Ropers, Vera M Kalscheuer.   

Abstract

Recently, we showed that truncation of the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene caused mental retardation and severe neurological symptoms in two female patients. Here, we report that de novo missense mutations in CDKL5 are associated with a severe phenotype of early-onset infantile spasms and clinical features that overlap those of other neurodevelopmental disorders, such as Rett syndrome and Angelman syndrome. The mutations are located within the protein kinase domain and affect highly conserved amino acids; this strongly suggests that impaired CDKL5 catalytic activity plays an important role in the pathogenesis of this neurodevelopmental disorder. In view of the overlapping phenotypic spectrum of CDKL5 and MECP2 mutations, it is tempting to speculate that these two genes play a role in a common pathogenic process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499549      PMCID: PMC1182152          DOI: 10.1086/426460

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA.

Authors:  J D Lewis; R R Meehan; W J Henzel; I Maurer-Fogy; P Jeppesen; F Klein; A Bird
Journal:  Cell       Date:  1992-06-12       Impact factor: 41.582

2.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.

Authors:  X Nan; H H Ng; C A Johnson; C D Laherty; B M Turner; R N Eisenman; A Bird
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

3.  Molecular cloning of the epidermal growth factor-stimulated protein kinase p56 KKIAMRE.

Authors:  C A Taglienti; M Wysk; R J Davis
Journal:  Oncogene       Date:  1996-12-19       Impact factor: 9.867

4.  Activation mechanism of the MAP kinase ERK2 by dual phosphorylation.

Authors:  B J Canagarajah; A Khokhlatchev; M H Cobb; E J Goldsmith
Journal:  Cell       Date:  1997-09-05       Impact factor: 41.582

Review 5.  Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification.

Authors:  S K Hanks; T Hunter
Journal:  FASEB J       Date:  1995-05       Impact factor: 5.191

6.  Structural basis of cyclin-dependent kinase activation by phosphorylation.

Authors:  A A Russo; P D Jeffrey; N P Pavletich
Journal:  Nat Struct Biol       Date:  1996-08

7.  Identification of NKIAMRE, the human homologue to the mitogen-activated protein kinase-/cyclin-dependent kinase-related protein kinase NKIATRE, and its loss in leukemic blasts with chromosome arm 5q deletion.

Authors:  M Midmer; R Haq; J A Squire; B W Zanke
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

8.  The distribution and biochemical properties of a Cdc2-related kinase, KKIALRE, in normal and Alzheimer brains.

Authors:  S H Yen; A Kenessey; S C Lee; D W Dickson
Journal:  J Neurochem       Date:  1995-12       Impact factor: 5.372

9.  Neonatal encephalopathy in two boys in families with recurrent Rett syndrome.

Authors:  N C Schanen; T W Kurczynski; D Brunelle; M M Woodcock; L S Dure; A K Percy
Journal:  J Child Neurol       Date:  1998-05       Impact factor: 1.987

10.  Rett variants: a suggested model for inclusion criteria.

Authors:  B A Hagberg; O H Skjeldal
Journal:  Pediatr Neurol       Date:  1994-07       Impact factor: 3.372

View more
  83 in total

1.  Regulation of seizure-induced MeCP2 Ser421 phosphorylation in the developing brain.

Authors:  Evan C Rosenberg; Jocelyn J Lippman-Bell; Marcus Handy; Samantha S Soldan; Sanjay Rakhade; Cristina Hilario-Gomez; Kaitlyn Folweiler; Leah Jacobs; Frances E Jensen
Journal:  Neurobiol Dis       Date:  2018-05-05       Impact factor: 5.996

Review 2.  Rett syndrome and the impact of MeCP2 associated transcriptional mechanisms on neurotransmission.

Authors:  Lisa M Monteggia; Ege T Kavalali
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

Review 3.  Balanced translocations in mental retardation.

Authors:  Geert Vandeweyer; R Frank Kooy
Journal:  Hum Genet       Date:  2009-04-05       Impact factor: 4.132

4.  Variation in novel exons (RACEfrags) of the MECP2 gene in Rett syndrome patients and controls.

Authors:  Periklis Makrythanasis; Philipp Kapranov; Lucia Bartoloni; Alexandre Reymond; Samuel Deutsch; Roderic Guigó; France Denoeud; Jorg Drenkow; Colette Rossier; Francesca Ariani; Valeria Capra; Laurent Excoffier; Alessandra Renieri; Thomas R Gingeras; Stylianos E Antonarakis
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

5.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy.

Authors:  Stephanie Fehr; Meredith Wilson; Jenny Downs; Simon Williams; Alessandra Murgia; Stefano Sartori; Marilena Vecchi; Gladys Ho; Roberta Polli; Stavroula Psoni; Xinhua Bao; Nick de Klerk; Helen Leonard; John Christodoulou
Journal:  Eur J Hum Genet       Date:  2012-08-08       Impact factor: 4.246

6.  Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and Rett-like features.

Authors:  Nils Rademacher; Melanie Hambrock; Ute Fischer; Bettina Moser; Berten Ceulemans; Wolfgang Lieb; Rainer Boor; Irina Stefanova; Gabriele Gillessen-Kaesbach; Charlotte Runge; Georg Christoph Korenke; Stefanie Spranger; Franco Laccone; Andreas Tzschach; Vera M Kalscheuer
Journal:  Neurogenetics       Date:  2011-02-12       Impact factor: 2.660

7.  CDKL5 and ARX mutations in males with early-onset epilepsy.

Authors:  Ghayda M Mirzaa; Alex R Paciorkowski; Eric D Marsh; Elizabeth M Berry-Kravis; Livija Medne; Asem Alkhateeb; Art Grix; Elaine C Wirrell; Berkley R Powell; Katherine C Nickels; Barbara Burton; Andrea Paras; Katherine Kim; Wendy Chung; William B Dobyns; Soma Das
Journal:  Pediatr Neurol       Date:  2013-05       Impact factor: 3.372

8.  Early myoclonic encephalopathy caused by a disruption of the neuregulin-1 receptor ErbB4.

Authors:  Liesbeth Backx; Berten Ceulemans; Joris Robert Vermeesch; Koen Devriendt; Hilde Van Esch
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

9.  Novel mutations in cyclin-dependent kinase-like 5 (CDKL5) gene in Indian cases of Rett syndrome.

Authors:  Dhanjit Kumar Das; Bhakti Mehta; Shyla R Menon; Sarbani Raha; Vrajesh Udani
Journal:  Neuromolecular Med       Date:  2012-12-15       Impact factor: 3.843

10.  Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.

Authors:  Joanne H Gibson; Barry Slobedman; Harikrishnan K N; Sarah L Williamson; Dimitri Minchenko; Assam El-Osta; Joshua L Stern; John Christodoulou
Journal:  BMC Neurosci       Date:  2010-04-26       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.